STRO
Sutro Biopharma·NASDAQ
--
--(--)
--
--(--)
2.51 / 10
Underperform
Technically, STRO is underperforming with a 2.51/10 score. Dominant bearish patterns—MACD Death Cross, Long Upper Shadow, and Long Lower Shadow—indicate declining momentum and elevated risk. The absence of bullish indicators and the negative trend in recent data underscore the need for caution.
Analysis Checks(0/3)
Long Upper Shadow
Score2.65/10
Win Rate44.66%
Hist. Signals103
Avg Return0.90%
Score2.65/10
Win Rate44.66%
Hist. Signals103
Avg Return0.90%
MACD Death Cross
Score3.87/10
Win Rate44.44%
Hist. Signals9
Avg Return3.62%
Score3.87/10
Win Rate44.44%
Hist. Signals9
Avg Return3.62%
Long Lower Shadow
Score1/10
Win Rate35.59%
Hist. Signals59
Avg Return-2.00%
Score1/10
Win Rate35.59%
Hist. Signals59
Avg Return-2.00%
Long Upper Shadow
Score2.65/10
Win Rate44.66%
Hist. Signals103
Avg Return0.90%
Score2.65/10
Win Rate44.66%
Hist. Signals103
Avg Return0.90%
Long Lower Shadow
Score1/10
Win Rate35.59%
Hist. Signals59
Avg Return-2.00%
Score1/10
Win Rate35.59%
Hist. Signals59
Avg Return-2.00%
MACD Death Cross
Score3.87/10
Win Rate44.44%
Hist. Signals9
Avg Return3.62%
Score3.87/10
Win Rate44.44%
Hist. Signals9
Avg Return3.62%
Technical Analysis of STRO?
- STRO presents a Underperform setup with a Technical Score of 2.51/10. Key technical indicators highlight an RSI of 61.73 and a MACD of -0.32, with the trend anchored by the 50-Day SMA at 11.70. Traders should monitor key support at 13.12 and resistance at 15.82.
